CellSource Co., Ltd. (JP:4880) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
CellSource Co., Ltd. has announced the establishment of a new subsidiary, Hybrid Medical Co., Ltd., to enhance collaboration with medical institutions in regenerative medicine, especially within orthopedics. The subsidiary will be wholly owned by CellSource and is set to begin operations in November 2024. This strategic move is expected to have a minimal impact on the company’s financial performance for the current fiscal year.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.